Research Roundup

Debbie Rigby takes a look at the latest in research news Aspirin deprescribing in primary prevention of cardiovascular disease Current evidence and practice guidelines do not recommend aspirin for primary prevention of cardiovascular disease. Pharmacists are well placed to assess the clinical appropriateness of aspirin in cardiovascular disease and initiate deprescribing as required with medical

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Coming up on the calendar
Next Chemist Warehouse accused of 'widespread underpayment'